James M. Dahle
Articles
-
1 month ago |
opmed.doximity.com | Abraham Kim |Erica Leigh Jacovetty |James M. Dahle
Nearly 41% of oncologists say molecular diagnostics and biomarker-driven therapy is the most exciting trend in their field, beating out other emerging trends like AI and immunotherapy, according to the results of a Doximity poll.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →